Muhammad Abdul‐Ghani

10.2k total citations · 3 hit papers
127 papers, 7.5k citations indexed

About

Muhammad Abdul‐Ghani is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Muhammad Abdul‐Ghani has authored 127 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Endocrinology, Diabetes and Metabolism, 67 papers in Molecular Biology and 43 papers in Surgery. Recurrent topics in Muhammad Abdul‐Ghani's work include Diabetes Treatment and Management (60 papers), Metabolism, Diabetes, and Cancer (48 papers) and Pancreatic function and diabetes (37 papers). Muhammad Abdul‐Ghani is often cited by papers focused on Diabetes Treatment and Management (60 papers), Metabolism, Diabetes, and Cancer (48 papers) and Pancreatic function and diabetes (37 papers). Muhammad Abdul‐Ghani collaborates with scholars based in United States, Qatar and United Kingdom. Muhammad Abdul‐Ghani's co-authors include Ralph A. DeFronzo, Ralph A. DeFronzo, Luke Norton, Devjit Tripathy, Roy Eldor, Giuseppe Daniele, Carolina Solis‐Herrera, Christopher P. Jenkinson, Aurora Merovci and Juan Xiong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Muhammad Abdul‐Ghani

124 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

2014 635 citations Aurora Merovci, Carolina Solis‐Herrera et al. profile →
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition

2016 414 citations Ralph A. DeFronzo, Luke Norton et al. profile →
Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

2011 352 citations Muhammad Abdul‐Ghani, Luke Norton et al. profile →

Peers

Muhammad Abdul‐Ghani

EDM

SURGE

PHYSI

EPIDE

Thomas Först Germany

Kohei Kaku Japan

Bernhard Ludvik Austria

Devjit Tripathy United States

Munehide Matsuhisa Japan

Ananda Basu United States

Agostino Consoli Italy

Sunder Mudaliar United States

Thomas Nyström Sweden

Åke Sjöholm Sweden

Thomas Först Germany

Muhammad Abdul‐Ghani

4.7k ×1.0

EDM

2.3k ×0.7

2.2k ×0.9

SURGE

958 ×0.6

PHYSI

1.0k ×1.1

EPIDE

Citations per year, relative to Muhammad Abdul‐Ghani Muhammad Abdul‐Ghani (= 1×) peers Thomas Först

Countries citing papers authored by Muhammad Abdul‐Ghani

Since Specialization

Citations

This map shows the geographic impact of Muhammad Abdul‐Ghani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Abdul‐Ghani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Abdul‐Ghani more than expected).

Fields of papers citing papers by Muhammad Abdul‐Ghani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Abdul‐Ghani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Abdul‐Ghani. The network helps show where Muhammad Abdul‐Ghani may publish in the future.

Co-authorship network of co-authors of Muhammad Abdul‐Ghani

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Abdul‐Ghani. A scholar is included among the top collaborators of Muhammad Abdul‐Ghani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Abdul‐Ghani. Muhammad Abdul‐Ghani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakhleh, Afif, Muhammad Abdul‐Ghani, Sivan Gazit, et al.. (2024). Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria. Diabetes Obesity and Metabolism. 26(8). 3058–3067. 4 indexed citations

Merovci, Aurora, et al.. (2024). Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects. BMJ Open Diabetes Research & Care. 12(5). e004199–e004199. 11 indexed citations

Khattab, Ahmed, et al.. (2023). The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals. Diabetes Obesity and Metabolism. 26(3). 1033–1039. 1 indexed citations

Shannon, Chris E., Aurora Merovci, Marcel Fourcaudot, et al.. (2022). Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects. The Journal of Clinical Endocrinology & Metabolism. 107(8). e3177–e3185. 3 indexed citations

Al‐Ozairi, Ebaa, et al.. (2022). A randomised crossover trial: Exploring the dose–response effect of carbohydrate restriction on glycaemia in people with well‐controlled type 2 diabetes. Journal of Human Nutrition and Dietetics. 36(1). 51–61. 3 indexed citations

Ryu, Jiyoon, Zhi Li, Feng Dong, et al.. (2021). Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration. Diabetes. 70(6). 1303–1316. 35 indexed citations

Ponirakis, Georgios, Muhammad Abdul‐Ghani, Amin Jayyousi, et al.. (2021). Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. Journal of Diabetes Investigation. 12(11). 2002–2009. 7 indexed citations

Gadeau, Alain‐Pierre, Rashid Ahmed, Anwarul Hasan, et al.. (2021). Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. International Journal of Molecular Sciences. 22(23). 12677–12677. 10 indexed citations

Ponirakis, Georgios, Muhammad Abdul‐Ghani, Amin Jayyousi, et al.. (2021). Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. Journal of Diabetes Investigation. 12(9). 1642–1650. 21 indexed citations

10.

Zhang, Lu, et al.. (2020). Regulation of ANGPTL8 in liver and adipose tissue by nutritional and hormonal signals and its effect on glucose homeostasis in mice. American Journal of Physiology-Endocrinology and Metabolism. 318(5). E613–E624. 18 indexed citations

11.

Daniele, Giuseppe, Carolina Solis‐Herrera, Angela Dardano, et al.. (2020). Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy. Diabetologia. 63(11). 2423–2433. 20 indexed citations

12.

Fiorentino, Teresa Vanessa, Adriana Monroy, Michele Dei, et al.. (2020). Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes. Metabolism. 114. 154416–154416. 32 indexed citations

13.

Abdul‐Ghani, Muhammad, Ralph A. DeFronzo, & Amin Jayyousi. (2016). Prediabetes and risk of diabetes and associated complications. Current Opinion in Clinical Nutrition & Metabolic Care. 19(5). 394–399. 36 indexed citations

14.

Bener, Abdülbari, et al.. (2014). Relationship between patient satisfactions with diabetes care and treatment. Nigerian Journal of Clinical Practice. 17(2). 218–218. 21 indexed citations

15.

DeFronzo, Ralph A. & Muhammad Abdul‐Ghani. (2011). Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention. Diabetes Care. 34(Supplement_2). S202–S209. 112 indexed citations

16.

DeFronzo, Ralph A. & Muhammad Abdul‐Ghani. (2011). Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose. The American Journal of Cardiology. 108(3). 3B–24B. 247 indexed citations

17.

Abdul‐Ghani, Muhammad, et al.. (2006). Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.. PubMed. 8(6). 378–82. 40 indexed citations

18.

Abdul‐Ghani, Muhammad, et al.. (2005). High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among overweight Arabs in Israel.. PubMed. 7(3). 143–7. 30 indexed citations

19.

Abdul‐Ghani, Muhammad, et al.. (2005). Association of high body mass index with low age of disease onset among Arab women with type 2 diabetes in a primary care clinic.. PubMed. 7(6). 360–3. 15 indexed citations

20.

Valiante, Taufik A., Muhammad Abdul‐Ghani, Peter L. Carlen, & Peter Pennefather. (1997). Analysis of current fluctuations during after‐hyperpolarization current in dentate granule neurones of the rat hippocampus.. The Journal of Physiology. 499(1). 121–134. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact